Lorna Warwick, BA, Lymphoma Coalition, Toronto, Canada, emphasizes the importance of addressing cancer patients’ fear of disease progression and relapse, and explains that patients should be encouraged to communicate their fears to their medical team to receive adequate support. This interview took place at the 49th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.